In addition, several studies have demonstrated that PARP inhibition may upregulate the expression of ligands of the activating receptor NKG2D on tumour cells via the induction of genotoxic stress and stalled DNA replication forks [59,60]. This evidence concerns the gene KLRK1 and neoplasm.